530 results on '"Brockow K"'
Search Results
52. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement
53. Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial
54. Definition of an exercise intensity threshold in a challenge test to diagnose food-dependent exercise-induced anaphylaxis
55. Anaphylaktischer Schock - Mastzellerkrankung oder nicht?: WS09/06
56. Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA2LEN platform. The Galenda project
57. Skin testing in patients with hypersensitivity reactions to iodinated contrast media – a European multicenter study
58. Topical miltefosine can reduce lesion size and wheal formation in cutaneous mastocytosis: 100
59. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients
60. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity
61. Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria
62. Diagnostik und Pathogenese von Arzneimittel-Intoleranzreaktionen der Haut: S22/03
63. Management of hypersensitivity reactions to iodinated contrast media
64. Diagnosis of nonimmediate reactions to β-lactam antibiotics
65. Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices.
66. Diagnosis of immediate allergic reactions to beta-lactam antibiotics
67. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations
68. Late-type reactions to radiographic contrast media
69. Mast cell activation in mastocytosis
70. General considerations for skin test procedures in the diagnosis of drug hypersensitivity
71. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole
72. Changes in collagen I and collagen III metabolism in patients with generalized atopic eczema undergoing medium-dose ultraviolet A1 phototherapy
73. Antihistamines in urticaria
74. Dihydroxyacetone (Autohélios®): A powerful therapeutical option in vitiligo: FC30–4
75. Exanthematous lichen planus in a child—response to acitretin
76. The Therapeutic Concept of “Patient Management” in Atopic Eczema
77. Cytochrome P450s are deactivators of the aryl hydrocarbon receptor in human immune cells
78. Drug allergy passport and other documentation for patients with drug hypersensitivity – An ENDA/EAACI Drug Allergy Interest Group Position Paper
79. Comparison of Molecular Multiplex and Singleplex Analysis of IgE to Grass Pollen Allergens in Untreated German Grass Pollen-Allergic Patients
80. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal
81. International Consensus on drug allergy
82. Standards and standardization in Mastocytosis: a consensus proposal and report of the year 2005 Working Conference on Mastocytosis
83. The Drug Ambassador Project - The diversity of diagnostic procedures for drug allergy around Europe
84. Diagnosis of immediate allergic reactions to beta-lactam antibiotics
85. Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio-oedema
86. Plantar Erythrodysesthesia Caused by Antiretroviral Treatment: A Case Report and Review of the Literature
87. Clinical and translational allergy / Research needs in allergy: an EAACI position paper, in collaboration with EFA
88. A high-troughput screening assay for detection of auto-IgE
89. Atopic eczema and allergic rhinitis show a dichotomic pattern of IgE-autoreactivity against skin, lung and intestinal epithelium
90. Research needs in allergy: An EAACI position paper, in collaboration with EFA
91. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice
92. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study
93. Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project
94. Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GA2LEN platform. The Galenda project
95. Schulungen.
96. Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/ EAACI Drug Allergy Interest Group Position Paper.
97. Kutane Mastozytose.
98. Urtikaria.
99. Psoriasis vulgaris.
100. Molluscum contagiosum.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.